BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

531 related articles for article (PubMed ID: 27519616)

  • 41. Intraoperative radiotherapy for oncological and function-preserving surgery in patients with advanced lower rectal cancer.
    Masaki T; Takayama M; Matsuoka H; Abe N; Ueki H; Sugiyama M; Tonari A; Kusuda J; Mizumoto S; Atomi Y
    Langenbecks Arch Surg; 2008 Mar; 393(2):173-80. PubMed ID: 18172677
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Thirty years' changes of the strategy of lateral lymph node dissection in low rectal cancer: treatment experience and prognostic analysis of 289 cases in one single center].
    Tang JQ; Li HY; Liu T; Zhang JL; Zuo S; Sun L; Wu YC; Jiang Y; Chen GW; Wu T; Wan YL; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Oct; 24(10):889-896. PubMed ID: 34674464
    [No Abstract]   [Full Text] [Related]  

  • 43. Meta-analysis of survival and functional outcomes after total mesorectal excision with or without lateral pelvic lymph node dissection in rectal cancer surgery.
    Hajibandeh S; Hajibandeh S; Matthews J; Palmer L; Maw A
    Surgery; 2020 Sep; 168(3):486-496. PubMed ID: 32620303
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Laparoscopic Lateral Lymph Node Dissection for Rectal Cancer with Lateral Lymph Node Metastasis - A Case Report].
    Jin H; Morohashi H; Sato K; Umetsu S; Yoshida T; Wakasa Y; Ichinohe D; Ogasawara H; Hasebe T; Miura T; Sakamoto Y; Hakamada K
    Gan To Kagaku Ryoho; 2016 Nov; 43(12):2292-2294. PubMed ID: 28133299
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Significance of preoperative radiotherapy and lateral lymph node dissection for locally advanced rectal cancer - a comparative study involving different hospitals].
    Onozawa H; Hatano S; Matsuzawa T; Fukuchi M; Kumagai Y; Baba H; Ishibashi K; Mochiki E; Kumamoto K; Nakamura I; Oki S; Ishida H; Takenoshita S
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):1557-9. PubMed ID: 25731251
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adjuvant chemotherapy with uracil-tegafur for pathological stage III rectal cancer after mesorectal excision with selective lateral pelvic lymphadenectomy: a multicenter randomized controlled trial.
    Akasu T; Moriya Y; Ohashi Y; Yoshida S; Shirao K; Kodaira S;
    Jpn J Clin Oncol; 2006 Apr; 36(4):237-44. PubMed ID: 16675478
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Oncological Outcomes of Lateral Pelvic Lymph Node Metastasis in Rectal Cancer Treated With Preoperative Chemoradiotherapy.
    Ishihara S; Kawai K; Tanaka T; Kiyomatsu T; Hata K; Nozawa H; Morikawa T; Watanabe T
    Dis Colon Rectum; 2017 May; 60(5):469-476. PubMed ID: 28383446
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sexual dysfunction after curative radical resection of rectal cancer in men: the role of extended systematic lymph-node dissection.
    Cöl C; Hasdemir O; Yalçin E; Yandakçi K; Tunç G; Kuçukpinar T
    Med Sci Monit; 2006 Feb; 12(2):CR70-4. PubMed ID: 16449950
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Risk factors for surgical site infection and association of surgical site infection with survival of lower rectal cancer patients without clinical lateral pelvic lymph node metastasis (clinical Stage II/III): Analysis of data from JCOG0212.
    Katsumata K; Enomoto M; Ishizaki T; Fujita S; Kanemitsu Y; Ito M; Shiomi A; Komori K; Ohue M; Ota M; Akazai Y; Shiozawa M; Yamaguchi T; Bando H; Sekimoto M; Kobatake T; Machida R; Akasu T; Moriya Y;
    Clin Exp Metastasis; 2021 Oct; 38(5):459-466. PubMed ID: 34406563
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Outcomes of surgery alone for lower rectal cancer with and without pelvic sidewall dissection.
    Kobayashi H; Mochizuki H; Kato T; Mori T; Kameoka S; Shirouzu K; Sugihara K
    Dis Colon Rectum; 2009 Apr; 52(4):567-76. PubMed ID: 19404054
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inspection of Perirectal Lymph Nodes by One-Step Nucleic Acid Amplification Predicts Lateral Lymph Node Metastasis in Advanced Rectal Cancer.
    Miyake Y; Mizushima T; Hata T; Takahashi H; Hanada H; Shoji H; Nomura M; Haraguchi N; Nishimura J; Matsuda C; Takemasa I; Doki Y; Maeda I; Mori M; Yamamoto H
    Ann Surg Oncol; 2017 Dec; 24(13):3850-3856. PubMed ID: 28924845
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Radical surgery with total mesorectal excision in patients with T1 rectal cancer.
    Kulu Y; Müller-Stich BP; Bruckner T; Gehrig T; Büchler MW; Bergmann F; Ulrich A
    Ann Surg Oncol; 2015; 22(6):2051-8. PubMed ID: 25331008
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Possible benefits of robot-assisted rectal cancer surgery regarding urological and sexual dysfunction: a systematic review and meta-analysis.
    Broholm M; Pommergaard HC; Gögenür I
    Colorectal Dis; 2015 May; 17(5):375-81. PubMed ID: 25515638
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Is prophylactic lateral lymph node dissection needed for lower rectal cancer? A single-center retrospective study.
    Kondo H; Yamaguchi S; Hirano Y; Aikawa M; Sato H; Okamoto K; Sakuramoto S; Koyama I
    BMC Surg; 2021 May; 21(1):261. PubMed ID: 34039328
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Oncological outcomes of robotic-assisted laparoscopic versus open lateral lymph node dissection for locally advanced low rectal cancer.
    Yamaguchi T; Kinugasa Y; Shiomi A; Kagawa H; Yamakawa Y; Furutani A; Manabe S; Yamaoka Y; Hino H
    Surg Endosc; 2018 Nov; 32(11):4498-4505. PubMed ID: 29721748
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Risk factors for and longitudinal course of male sexual dysfunction after robotic rectal cancer surgery.
    Hanaoka M; Kagawa H; Shiomi A; Hino H; Manabe S; Yamaoka Y; Kinugasa Y
    Colorectal Dis; 2023 May; 25(5):932-942. PubMed ID: 36738158
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Outcomes and prognostic factors of selective lateral pelvic lymph node dissection with preoperative chemoradiotherapy for locally advanced rectal cancer.
    Matsuda T; Sumi Y; Yamashita K; Hasegawa H; Yamamoto M; Matsuda Y; Kanaji S; Oshikiri T; Nakamura T; Suzuki S; Kakeji Y
    Int J Colorectal Dis; 2018 Apr; 33(4):367-374. PubMed ID: 29442155
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Phase II/III randomized controlled trial comparing perioperative versus postoperative chemotherapy with mFOLFOX6 for lower rectal cancer with suspected lateral pelvic node metastasis: Japan Clinical Oncology Group Study JCOG1310 (PRECIOUS study).
    Ohue M; Iwasa S; Kanemitsu Y; Hamaguchi T; Shiozawa M; Ito M; Yasui M; Katayama H; Mizusawa J; Shimada Y;
    Jpn J Clin Oncol; 2017 Jan; 47(1):84-87. PubMed ID: 27655905
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dissection of the inferior mesenteric vein versus of the inferior mesenteric artery for the genitourinary function after laparoscopic approach of rectal cancer surgery: a randomized controlled trial.
    Pallisera-Lloveras A; Planelles-Soler P; Hannaoui N; Mora-López L; Muñoz-Rodriguez J; Serra-Pla S; Dominguez-Garcia A; Prats-López J; Navarro-Soto S; Serra-Aracil X;
    BMC Urol; 2019 Aug; 19(1):75. PubMed ID: 31382934
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intramural and mesorectal distal spread detected by whole-mount sections in the determination of optimal distal resection margin in patients undergoing surgery for rectosigmoid or rectal cancer without preoperative therapy.
    Shimada Y; Takii Y; Maruyama S; Ohta T
    Dis Colon Rectum; 2011 Dec; 54(12):1510-20. PubMed ID: 22067179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.